These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8001648)

  • 1. Effects of ABT-418, a novel cholinergic channel ligand, on place learning in septal-lesioned rats.
    Decker MW; Curzon P; Brioni JD; Arnerić SP
    Eur J Pharmacol; 1994 Aug; 261(1-2):217-22. PubMed ID: 8001648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride]: II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeys.
    Decker MW; Bannon AW; Curzon P; Gunther KL; Brioni JD; Holladay MW; Lin NH; Li Y; Daanen JF; Buccafusco JJ; Prendergast MA; Jackson WJ; Arneric SP
    J Pharmacol Exp Ther; 1997 Oct; 283(1):247-58. PubMed ID: 9336330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
    Arneric SP; Sullivan JP; Briggs CA; Donnelly-Roberts D; Anderson DJ; Raszkiewicz JL; Hughes ML; Cadman ED; Adams P; Garvey DS
    J Pharmacol Exp Ther; 1994 Jul; 270(1):310-8. PubMed ID: 7518514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.
    Decker MW; Brioni JD; Sullivan JP; Buckley MJ; Radek RJ; Raszkiewicz JL; Kang CH; Kim DJ; Giardina WJ; Wasicak JT
    J Pharmacol Exp Ther; 1994 Jul; 270(1):319-28. PubMed ID: 7913497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiolytic-like effects of the novel cholinergic channel activator ABT-418.
    Brioni JD; O'Neill AB; Kim DJ; Buckley MJ; Decker MW; Arneric SP
    J Pharmacol Exp Ther; 1994 Oct; 271(1):353-61. PubMed ID: 7965735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement in performance of a delayed matching-to-sample task by monkeys following ABT-418: a novel cholinergic channel activator for memory enhancement.
    Buccafusco JJ; Jackson WJ; Terry AV; Marsh KC; Decker MW; Arneric SP
    Psychopharmacology (Berl); 1995 Aug; 120(3):256-66. PubMed ID: 8524972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential treatment of Alzheimer disease using cholinergic channel activators (ChCAs) with cognitive enhancement, anxiolytic-like, and cytoprotective properties.
    Arneric SP; Sullivan JP; Decker MW; Brioni JD; Bannon AW; Briggs CA; Donnelly-Roberts D; Radek RJ; Marsh KC; Kyncl J
    Alzheimer Dis Assoc Disord; 1995; 9 Suppl 2():50-61. PubMed ID: 8534424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlordiazepoxide improves the performance of septal lesioned but not hippocampal lesioned animals in a Morris maze.
    Farber HT
    Brain Res; 1996 Jul; 725(2):257-62. PubMed ID: 8836533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of the effects of ABT-418 and methylphenidate on spatial memory in an animal model of ADHD.
    Guo T; Yang C; Guo L; Liu K
    Neurosci Lett; 2012 Oct; 528(1):11-5. PubMed ID: 22985505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nicotine on spatial memory deficits in rats with septal lesions.
    Decker MW; Majchrzak MJ; Anderson DJ
    Brain Res; 1992 Feb; 572(1-2):281-5. PubMed ID: 1611524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABT-418: discriminative stimulus properties and effect on ventral tegmental cell activity.
    Brioni JD; Kim DJ; Brodie MS; Decker MW; Arneric SP
    Psychopharmacology (Berl); 1995 Jun; 119(4):368-75. PubMed ID: 7480515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIB-1553A, (+/-)-4-[[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride, a subtype-selective ligand for nicotinic acetylcholine receptors with putative cognitive-enhancing properties: effects on working and reference memory performances in aged rodents and nonhuman primates.
    Bontempi B; Whelan KT; Risbrough VB; Rao TS; Buccafusco JJ; Lloyd GK; Menzaghi F
    J Pharmacol Exp Ther; 2001 Oct; 299(1):297-306. PubMed ID: 11561092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GABAergic septohippocampal neurons are not necessary for spatial memory.
    Pang KC; Nocera R; Secor AJ; Yoder RM
    Hippocampus; 2001; 11(6):814-27. PubMed ID: 11811676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticholinergic sensitivity in the aging rat septohippocampal system as assessed in a spatial memory task.
    Nilsson OG; Gage FH
    Neurobiol Aging; 1993; 14(5):487-97. PubMed ID: 8247231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central nicotinic receptor agonists ABT-418, ABT-089, and (-)-nicotine reduce distractibility in adult monkeys.
    Prendergast MA; Jackson WJ; Terry AV; Decker MW; Arneric SP; Buccafusco JJ
    Psychopharmacology (Berl); 1998 Mar; 136(1):50-8. PubMed ID: 9537682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galantamine-induced behavioral recovery after sublethal excitotoxic lesions to the rat medial septum.
    Mulder J; Harkany T; Czollner K; Cremers TI; Keijser JN; Nyakas C; Luiten PG
    Behav Brain Res; 2005 Aug; 163(1):33-41. PubMed ID: 15951032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic treatment with GPI 1046 improves spatial memory and reverses cholinergic neuron atrophy in the medial septal nucleus of aged mice.
    Sauer H; Francis JM; Jiang H; Hamilton GS; Steiner JP
    Brain Res; 1999 Sep; 842(1):109-18. PubMed ID: 10526101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The selective 5-HT3 receptor antagonist, WAY100289, enhances spatial memory in rats with ibotenate lesions of the forebrain cholinergic projection system.
    Hodges H; Sowinski P; Sinden JD; Netto CA; Fletcher A
    Psychopharmacology (Berl); 1995 Feb; 117(3):318-32. PubMed ID: 7770608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct profile of working memory errors following acute or chronic disruption of the cholinergic septohippocampal pathway.
    Stackman RW; Walsh TJ
    Neurobiol Learn Mem; 1995 Nov; 64(3):226-36. PubMed ID: 8564376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of sustained attention performance by the nicotinic acetylcholine receptor agonist ABT-418 in intact but not basal forebrain-lesioned rats.
    McGaughy J; Decker MW; Sarter M
    Psychopharmacology (Berl); 1999 May; 144(2):175-82. PubMed ID: 10394999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.